cas 121-89-1|| where to buy 3'-Nitroacetophenone

Nom du produit:3'-Nitroacetophenone

IUPAC Name:1-(3-nitrophenyl)ethan-1-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM248294-1000g	in stock	Ǫƈ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 121-89-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:121-89-1; Formule moléculaire:C8H7NO3; Point de fusion:-; Code SMILES:CC(C1=CC=CC([N+]([O-])=O)=C1)=O; Densité:

: Numéro de catalogue:CM248294; Poids moléculaire:165.15; Point d'ébullition:237.3°C at 760 mmHg; N° Mdl:MFCD00007259; Stockage:Store at room temperature.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Seralutinib; Gossamer Bio and Chiesi Farmaceutici announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib. Seralutinib is an inhaled PDGFRα/β, CSF1R, and c-KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary hypertension.